Dashboard
Manage Tickers

CLNNClene Inc.

Nasdaq clene.com


$ 0.38 $ 0.01 (1.3 %)    

Friday, 21-Jun-2024 15:59:47 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.04 $ -0.13 (-0.03 %)
DIA $ 392.46 $ 0.00 (0 %)
SPY $ 544.33 $ -0.07 (-0.01 %)
TLT $ 93.99 $ 0.24 (0.26 %)
GLD $ 215.73 $ 0.14 (0.06 %)
$ 0.3963
$ 0.39
$ 0.00 x 0
$ 0.00 x 0
$ 0.38 - $ 0.41
$ 0.25 - $ 0.97
1,399,037
na
50.9M
$ 0.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-13-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-13-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-11-2022 12-31-2021 10-K
11 11-08-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-29-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-clene-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Clen...
06/21/2024 17:44:02

HC Wainwright & Co. analyst Joseph Pantginis reiterates Clene (NASDAQ:CLNN) with a Buy and maintains $7 price target.

clene-presents-preliminary-data-for-cnm-au8-as-a-potential-treatment-for-rett-syndrome--data-unveiled-in-oral-and-poster-presentations-on-june-19-at-the-international-rett-syndrome-foundation-2024-annual-meeting-in-westminster-colorado
Clene Presents Preliminary Data For CNM-Au...
06/21/2024 11:13:55

CNM-Au8 is an orally administered, catalytic nanotherapeutic that targets energy metabolism via mitochondria in nervous system ...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
06/20/2024 20:31:11

analyst-scoreboard-5-ratings-for-clene
Analyst Scoreboard: 5 Ratings For Clene
06/18/2024 18:00:29

hc-wainwright--co-reiterates-buy-on-clene-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Clen...
06/18/2024 16:26:57

HC Wainwright & Co. analyst Joseph Pantginis reiterates Clene (NASDAQ:CLNN) with a Buy and maintains $7 price target.

clene-presented-new-long-term-cnm-au8-treatment-results-for-survival-and-neurofilament-light-levels-from-healey-als-platform-trial-open-label-extension-at-the-european-network-for-the-cure-of-als-meeting
Clene Presented New Long-term CNM-AU8 Trea...
06/18/2024 11:09:10

Survival analyses with CNM-Au8 30 mg treatment compared to matched PRO-ACT controls demonstrated improved survival up to 3.5 ...

why-oracle-shares-are-trading-higher-by-9-here-are-20-stocks-moving-premarket
Why Oracle Shares Are Trading Higher By 9%...
06/12/2024 09:33:47

hc-wainwright--co-reiterates-buy-on-clene-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Clen...
05/28/2024 15:59:16

HC Wainwright & Co. analyst Joseph Pantginis reiterates Clene (NASDAQ:CLNN) with a Buy and maintains $7 price target.

clenes-nih-funded-als-program-for-cnm-au8-expands-enrollment-by-80-launches-data-collection-in-june
Clene's NIH-Funded ALS Program For CNM-Au8...
05/28/2024 12:14:52

analyst-scoreboard-6-ratings-for-clene
Analyst Scoreboard: 6 Ratings For Clene
05/23/2024 14:01:19

benchmark-reiterates-buy-on-clene-maintains-5-price-target
Benchmark Reiterates Buy on Clene, Maintai...
05/23/2024 13:45:12

Benchmark analyst Bruce Jackson reiterates Clene (NASDAQ:CLNN) with a Buy and maintains $5 price target.

hc-wainwright--co-reiterates-buy-on-clene-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Clen...
05/08/2024 15:43:14

HC Wainwright & Co. analyst Joseph Pantginis reiterates Clene (NASDAQ:CLNN) with a Buy and maintains $7 price target.

clene-q1-eps-009-misses-008-estimate-sales-7300k-miss-12000k-estimate
Clene Q1 EPS $(0.09) Misses $(0.08) Estima...
05/08/2024 12:28:55

Clene (NASDAQ:CLNN) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.08) by 12...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
05/06/2024 20:31:06

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
04/19/2024 20:31:47

the-analyst-verdict-clene-in-the-eyes-of-5-experts
The Analyst Verdict: Clene In The Eyes Of ...
04/17/2024 20:02:08

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
04/17/2024 12:08:12

hc-wainwright--co-reiterates-buy-on-clene-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Clen...
04/17/2024 10:42:49

HC Wainwright & Co. analyst Joseph Pantginis reiterates Clene (NASDAQ:CLNN) with a Buy and maintains $7 price target.

why-invo-bioscience-shares-are-trading-higher-by-around-73-here-are-20-stocks-moving-premarket
Why INVO Bioscience Shares Are Trading Hig...
04/17/2024 10:13:57

Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/16/2024 20:31:56

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)